Advertisement
News
Advertisement

Bayer and Regeneron Announce Start of Phase 3 Clinical Program in Diabetic Macular Edema

Fri, 04/15/2011 - 4:23am
Bayer

Topics

Advertisement
Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading